The next board meeting for Vivos Therapeutics Inc is on 14 Aug 2025 for the purpose of Vivos Therapeutics Inc Second Quarter Earnings Results for 2025See details
Vivos Therapeutics Inc has a share price target of US$ 4, revenue growth forecast of -6.9%, and profit growth estimate of -22.6% for FY25, based on top 2 analyst calls.